Dr. Nguyen is Professor of Medicine, a Stanford Cancer Institute member and specializes in the treatment and prevention of primary liver cancer such as hepatocellular carcinoma (HCC).

Ming-Lung Yu is the President and a Chair Professor of Kaohsiung Medical University (KMU), Taiwan. He is also an adjunct chair professor of National Sun Yat-sen University(NSYSU). Professor Yu's research interests in Hepatology, including epidemiology, natural course, risk stratification, treatment and prognosis of HBV and HCV, as well as MASLD, have led him to publish more than 550 scientific original and review articles.

Dr. Gawrieh is Professor of Medicine at Indiana University School of Medicine. His research investigates the genetic and environmental modifiers, diagnostics and therapeutics of metabolic dysfunction- and alcohol-associated steatotic liver disease.

Rebecca Wells is a Professor of Medicine with a secondary appointment in Bioengineering at the University of Pennsylvania, where she has been on the faculty for more than 20 years. She received a medical degree from Johns Hopkins University and did postdoctoral research training at Brigham and Women's Hospital/Harvard University and the Whitehead Institute. Her lab studies the intersection between the extracellular matrix and mechanics as applied to wound healing, using the liver and biliary tree as model tissues.

Binu V. John, MD, MPH, FACG, AGAF, FAASLD
Associate Professor of Medicine, University of Miami Miller School of Medicine
Chief of Gastroenterology and Hepatology, Miami VA Healthcare System
Dr. Binu John is Associate Professor of Medicine at the University of Miami Miller School of Medicine and Chief of Gastroenterology and Hepatology at the Miami VA Healthcare System. He serves as GI Lead for VISN 8, encompassing seven VA medical centers across Florida and Puerto Rico.

I am a physician-scientist and hepatologist at the University of Southern California with a research interest in Drug-Induced Liver Injury and Autoimmune Liver Diseases. I study mechanisms of liver injury and hepatotoxicity with a particular focus on cell death pathways using basic, animal model, and translational approaches. My lab currently focuses on Immune-mediated Liver Injury from Checkpoint Inhibitors and the complex interplay if signaling mechanisms leading to hepatotoxicity in immunotherapy.

Dr. Jesudian is a Transplant Hepatologist whose research focuses on improving outcomes in patients with cirrhosis and complications of portal hypertension through quality improvement. He is an Associate Professor of Clinical Medicine, Director of Liver Quality and Inpatient Liver Services at NewYork-Presbyterian Hospital/Weill Cornell Medicine. He serves as Chair-Elect of the Practice Metrics Committee.

Indira Bhavsar-Burke, M.D., M.H.P.E., is an Assistant Professor in the Division of Digestive and Liver Diseases at UT Southwestern Medical Center, where she serves as Associate Program Director for the Internal Medicine Residency and Gastroenterology Fellowship programs. With interests in ACLF and medical education, her academic work focuses largely on faculty development, competency-based education, and coaching in graduate medical education. She also serves on the ABIM Gastroenterology Subspecialty Board.

Elliot Tapper, FAASLD is Professor at the University of Michigan

Dr. Christina Lindenmeyer is an Associate Professor of Medicine and Transplant Hepatologist in the Department of Gastroenterology, Hepatology and Nutrition. After graduating from Jefferson Medical College in Philadelphia, Dr. Lindenmeyer completed her residency in Internal Medicine at Thomas Jefferson University Hospital. She then completed fellowships in Gastroenterology and Transplant Hepatology at the Cleveland Clinic in Cleveland, Ohio.​